IDEAYA Biosciences, Inc. (IDYA)
NGS · Common · CUSIP 45166A102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IDYA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45166A102
Market Cap
Small Cap · $344 Million
IPO
5/23/2019 · $10.00/share
Business: IDEAYA Biosciences, Inc. is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The Company's approach integrates capabilities in identifying and validating predictive biomarkers with small molecule drug discovery to select patient populations most likely to benefit from our targeted therapies.

Company Contact

CEO
Yujiro Hata
CFO
Paul A. Stone
Headquarters
7000 Shoreline Court, Suite 350, South San Francisco, CA 94080
Phone
650-443-6209
Investor Relations
Paul Stone · 650-443-6209 · pstone@ideayabio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »